Page last updated: 2024-10-26

dipyridamole and Cardiotoxicity

dipyridamole has been researched along with Cardiotoxicity in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research Excerpts

ExcerptRelevanceReference
" Doxorubicin caused cardiotoxicity as indicated by a significant increase in tumor necrosis factor-α, interleukin-6, malondialdehyde, and caspase-3 level (P<0."8.12Dipyridamole ameliorates doxorubicin-induced cardiotoxicity. ( Alyasiry, E; Hadi, N; Janabi, A, 2022)
" Doxorubicin caused cardiotoxicity as indicated by a significant increase in tumor necrosis factor-α, interleukin-6, malondialdehyde, and caspase-3 level (P<0."4.12Dipyridamole ameliorates doxorubicin-induced cardiotoxicity. ( Alyasiry, E; Hadi, N; Janabi, A, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alyasiry, E3
Janabi, A3
Hadi, N3
MARINO, A1

Other Studies

2 other studies available for dipyridamole and Cardiotoxicity

ArticleYear
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
Dipyridamole ameliorates doxorubicin-induced cardiotoxicity.
    Journal of medicine and life, 2022, Volume: 15, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Dipyridamole; Doxorubicin; Interleukin

2022
INFLUENCE OF PSYCHOLOGICAL STRESS ON THE SPECIFIC CARDIOTOXICITY OF DRUGS.
    Nature, 1964, Sep-19, Volume: 203

    Topics: Angiotensins; Antihypertensive Agents; Carbamates; Cardiotoxicity; Dipyridamole; Electrocardiography

1964